Agenus, Inc. (AGEN):企業の財務及び戦略的SWOT分析

◆英語タイトル:Agenus, Inc. (AGEN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4419FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年4月1日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Agenus, Inc. (AGEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Agenus, Inc. (Agenus) is a pharmaceutical company. It focuses on the development and commercialization of immunotherapeutics for the treatment of diseases in the fields of cancer and infectious diseases. The company’s key technology portfolio includes Checkpoint Antibody Program, Saponin Platform and Heat Shock Protein (HSP) Platform. Its business activities include product research and development, regulatory and clinical affairs, manufacturing, corporate finance and development, business development, marketing, intellectual property prosecution and administrative functions. The company’s marketed product, Oncophage is an investigational patient-specific vaccine designed to treat renal cell carcinoma (kidney cancer). Its lead products in the pipeline include candidates for the treatment of genital herpes, glioma, and multiple cancer types, infectious diseases and Alzheimer’s disease. The company has strong partnerships with many pharmaceutical companies such as GSK and Janssen and universities such as UC San Francisco and UW Seattle. It operates in the US and Europe. Agenus is headquartered in Lexington, Massachusetts, the US.

Agenus, Inc. Key Recent Developments

Feb 26, 2015: Agenus Reports Fourth Quarter and Full Year 2014 Financial Results
Oct 24, 2013: Agenus Reports Third Quarter 2013 Financial Results
Oct 16, 2013: Agenus to Report Third Quarter 2013 Financial Results on October 24, 2013; Conference Call to Follow
Sep 18, 2013: Agenus to Participate in Brain Cancer Vaccine and Immunotherapy Discussion
Sep 04, 2013: Agenus to Present at two Upcoming Healthcare Conferences Upcoming Healthcare Conferences

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 – About the Company 6
Agenus, Inc. – Key Facts 6
Agenus, Inc. – Key Employees 7
Agenus, Inc. – Key Employee Biographies 8
Agenus, Inc. – Major Products and Services 9
Agenus, Inc. – Pharmaceutical Pipeline Products Data 10
Agenus, Inc., Pipeline Products by Therapy Area 10
Agenus, Inc., Pipeline Products by Development Phase 11
Agenus, Inc. – History 13
Agenus, Inc. – Company Statement 17
Agenus, Inc. – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Section 2 – Company Analysis 20
Agenus, Inc. – Business Description 20
Agenus, Inc. – Corporate Strategy 21
Agenus, Inc. – SWOT Analysis 22
SWOT Analysis – Overview 22
Agenus, Inc. – Strengths 22
Strength – Partnerships and Collaborations 22
Strength – Strong In-house Research Capabilities 22
Strength – Technology Platforms 22
Agenus, Inc. – Weaknesses 24
Weakness – Lack of Marketed Products 24
Weakness – Competitive Positioning 24
Agenus, Inc. – Opportunities 25
Opportunity – Market Potential for QS-21 Adjuvant 25
Opportunity – Strategic Initiatives 25
Opportunity – Orphan Drug and Fast Track Designations 25
Agenus, Inc. – Threats 26
Threat – Competitive Environment 26
Threat – Dependence on Collaborators and Licensees 26
Threat – Patent Expiry 26
Agenus, Inc. – Key Competitors 27
Section 3 – Company Financial Ratios 28
Financial Ratios – Capital Market Ratios 28
Financial Ratios – Annual Ratios 29
Performance Chart 30
Financial Performance 30
Financial Ratios – Interim Ratios 31
Financial Ratios – Ratio Charts 32
Section 4 – Company’s Lifesciences Financial Deals and Alliances 33
Agenus, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 33
Agenus, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 34
Agenus, Inc., Recent Deals Summary 35
Section 5 – Company’s Recent Developments 36
Feb 26, 2015: Agenus Reports Fourth Quarter and Full Year 2014 Financial Results 36
Oct 31, 2014: Agenus Reports Third Quarter 2014 Financial Results 38
Aug 04, 2014: Agenus to Present at Cambridge Healthtech Institute Second Annual Conference on Immunomodulatory Therapeutic Antibodies for Cancer 39
Jul 24, 2014: Agenus Reports Second Quarter 2014 Financial Results 40
Jun 16, 2014: Agenus Selected for Inclusion in the Russell 3000 Index and Global Index 42
Jun 16, 2014: Agenus (AGEN) Selected For Inclusion In The Russell 3000 Index And Global Index 43
May 08, 2014: Agenus Reports First Quarter 2014 Financial Results 44
Mar 05, 2014: Agenus Reports Fourth Quarter and Full Year 2013 Financial Results 46
Mar 05, 2014: Agenus to Advance Three Checkpoint Modulator Antibodies into Development 48
Jan 13, 2014: Agenus Appoints Robert B. Stein, MD, PhD, as Chief Scientific Officer 49
Section 6 – Appendix 50
Methodology 50
Ratio Definitions 50
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Agenus, Inc., Key Facts 6
Agenus, Inc., Key Employees 7
Agenus, Inc., Key Employee Biographies 8
Agenus, Inc., Major Products and Services 9
Agenus, Inc., Number of Pipeline Products by Therapy Area 10
Agenus, Inc., Number of Pipeline Products by Development Stage 11
Agenus, Inc., Pipeline Products By Therapy Area and Development Phase 12
Agenus, Inc., History 13
Agenus, Inc., Subsidiaries 19
Agenus, Inc., Key Competitors 27
Agenus, Inc., Ratios based on current share price 28
Agenus, Inc., Annual Ratios 29
Agenus, Inc., Interim Ratios 31
Agenus, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 33
Agenus, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 34
Agenus, Inc., Recent Deals Summary 35
Currency Codes 50
Capital Market Ratios 50
Equity Ratios 51
Profitability Ratios 51
Cost Ratios 52
Liquidity Ratios 52
Leverage Ratios 53
Efficiency Ratios 53

List of Figures
Agenus, Inc., Pipeline Products by Therapy Area 10
Agenus, Inc., Pipeline Products by Development Phase 11
Agenus, Inc., Performance Chart (2010 - 2014) 30
Agenus, Inc., Ratio Charts 32
Agenus, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 33
Agenus, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 34

★調査レポート[Agenus, Inc. (AGEN):企業の財務及び戦略的SWOT分析] (コード:GDPH4419FSA)販売に関する免責事項を必ずご確認ください。
★調査レポート[Agenus, Inc. (AGEN):企業の財務及び戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆